Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1980 1
1982 1
1984 1
1985 2
1986 2
1987 1
1988 2
1989 1
2000 3
2005 2
2006 8
2007 4
2008 3
2009 3
2010 7
2011 14
2012 16
2013 9
2014 9
2015 16
2016 6
2017 6
2018 7
2019 5
2020 6
2021 14
2022 17
2023 13
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
ATP synthesis and storage.
Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, Pinton P. Bonora M, et al. Among authors: poletti f. Purinergic Signal. 2012 Sep;8(3):343-57. doi: 10.1007/s11302-012-9305-8. Epub 2012 Apr 12. Purinergic Signal. 2012. PMID: 22528680 Free PMC article. Review.
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
HPS3/TIMI55–REVEAL Collaborative Group; Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. HPS3/TIMI55–REVEAL Collaborative Group, et al. N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28. N Engl J Med. 2017. PMID: 28847206 Free article. Clinical Trial.
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
Capone S, Fusco FM, Milleri S, Borrè S, Carbonara S, Lo Caputo S, Leone S, Gori G, Maggi P, Cascio A, Lichtner M, Cauda R, Dal Zoppo S, Cossu MV, Gori A, Roda S, Confalonieri P, Bonora S, Missale G, Codeluppi M, Mezzaroma I, Capici S, Pontali E, Libanore M, Diani A, Lanini S, Battella S, Contino AM, Piano Mortari E, Genova F, Parente G, Dragonetti R, Colloca S, Visani L, Iannacone C, Carsetti R, Folgori A, Camerini R; COVITAR study group. Capone S, et al. Cell Rep Med. 2023 Jun 20;4(6):101084. doi: 10.1016/j.xcrm.2023.101084. Epub 2023 May 29. Cell Rep Med. 2023. PMID: 37315558 Free PMC article. Clinical Trial.
Mitochondrial calcium homeostasis as potential target for mitochondrial medicine.
Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, Suski JM, Wieckowski MR, Pinton P. Giorgi C, et al. Among authors: poletti f. Mitochondrion. 2012 Jan;12(1):77-85. doi: 10.1016/j.mito.2011.07.004. Epub 2011 Jul 21. Mitochondrion. 2012. PMID: 21798374 Free PMC article. Review.
Mitochondria-associated membranes (MAMs) as hotspot Ca(2+) signaling units.
Bononi A, Missiroli S, Poletti F, Suski JM, Agnoletto C, Bonora M, De Marchi E, Giorgi C, Marchi S, Patergnani S, Rimessi A, Wieckowski MR, Pinton P. Bononi A, et al. Among authors: poletti f. Adv Exp Med Biol. 2012;740:411-37. doi: 10.1007/978-94-007-2888-2_17. Adv Exp Med Biol. 2012. PMID: 22453952 Review.
Fiber-delivered heterodyne spectroscopy with a mid-infrared frequency comb.
Castro-Marin P, Johnson K, Farrell C, Davidson IA, Fu Q, Jasion GT, Wheeler NV, Poletti F, Richardson DJ, Reid DT. Castro-Marin P, et al. Among authors: poletti f. Opt Express. 2023 Oct 9;31(21):34064-34073. doi: 10.1364/OE.501617. Opt Express. 2023. PMID: 37859171 Free article.
Redox control of protein kinase C: cell- and disease-specific aspects.
Giorgi C, Agnoletto C, Baldini C, Bononi A, Bonora M, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, Zavan B, Pinton P. Giorgi C, et al. Among authors: poletti f. Antioxid Redox Signal. 2010 Oct 1;13(7):1051-85. doi: 10.1089/ars.2009.2825. Antioxid Redox Signal. 2010. PMID: 20136499 Review.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
175 results